Incannex Healthcare Inc. (NASDAQ: IXHL) Stock Information | RedChip

Incannex Healthcare Inc. (NASDAQ: IXHL)


$2.57
+0.0200 ( +0.78% ) 28.1K

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.

Market Data


Open


$2.57

Previous close


$2.55

Volume


28.1K

Market cap


$44.81M

Day range


$2.39 - $2.67

52 week range


$0.80 - $12.68

SEC Fillings


Form Type Description Pages Date
6-k Quarterly Reports 292 Oct 05, 2023
6-k Quarterly Reports 3 Sep 08, 2023
6-k Quarterly Reports 2 Sep 01, 2023
6-k Quarterly Reports 14 Sep 01, 2023
6-k Quarterly Reports 3 Aug 24, 2023
6-k Quarterly Reports 3 Aug 22, 2023
6-k Quarterly Reports 3 Aug 10, 2023
6-k Quarterly Reports 3 Aug 08, 2023
6-k Quarterly Reports 3 Aug 01, 2023
6-k Quarterly Reports 3 Jul 28, 2023

Latest News